Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:


Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,002,769

« Back to Dashboard

Summary for Patent: 5,002,769

Title: Compositions for the sustained-release of chlorhexidine
Abstract:The present invention pertains to biodegradable sustained-release compositions capable of achieving the sustained release of chlorhexidine. The compositions can be formed into implant devices which may be used to treat a wide variety of diseases and conditions. The implants are especially useful in treating diseases such as periodontal disease which require prolonged drug release.
Inventor(s): Friedman; Michael (Jerusalem, IL)
Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem (Jerusalem, IL)
Application Number:07/324,505
Patent Claim Types:
see list of patent claims
Composition; Device; Use;

No matches for this query

International Patent Family for Patent: 5,002,769

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria119391► Subscribe
Australia5118990► Subscribe
Australia621521► Subscribe
Canada2011637► Subscribe
Germany69017484► Subscribe
Denmark0388220► Subscribe
European Patent Office0388220► Subscribe
Spain2068999► Subscribe
Japan2960098► Subscribe
JapanH03200726► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus